Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biodesix, Inc. stock logo
BDSX
Biodesix
$7.60
-2.9%
$8.12
$3.44
$34.40
$55.71M0.98199,870 shs17,376 shs
DocGo Inc. stock logo
DCGO
DocGo
$1.17
-2.2%
$1.50
$1.12
$5.68
$113.17M0.95791,078 shs981,886 shs
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
$2.41
-3.8%
$2.49
$1.35
$3.27
$104.47M0.6536,972 shs202,927 shs
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
$3.03
-5.3%
$2.91
$1.37
$9.13
$114.14M0.97197,351 shs30,960 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biodesix, Inc. stock logo
BDSX
Biodesix
+1.03%+1.69%-15.66%+26.86%-76.13%
DocGo Inc. stock logo
DCGO
DocGo
-4.76%-6.25%-24.05%-19.46%-62.50%
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
-2.34%-4.94%-3.47%+33.69%-6.72%
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
+1.59%+2.24%+3.23%+12.68%-50.23%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biodesix, Inc. stock logo
BDSX
Biodesix
$7.60
-2.9%
$8.12
$3.44
$34.40
$55.71M0.98199,870 shs17,376 shs
DocGo Inc. stock logo
DCGO
DocGo
$1.17
-2.2%
$1.50
$1.12
$5.68
$113.17M0.95791,078 shs981,886 shs
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
$2.41
-3.8%
$2.49
$1.35
$3.27
$104.47M0.6536,972 shs202,927 shs
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
$3.03
-5.3%
$2.91
$1.37
$9.13
$114.14M0.97197,351 shs30,960 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biodesix, Inc. stock logo
BDSX
Biodesix
+1.03%+1.69%-15.66%+26.86%-76.13%
DocGo Inc. stock logo
DCGO
DocGo
-4.76%-6.25%-24.05%-19.46%-62.50%
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
-2.34%-4.94%-3.47%+33.69%-6.72%
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
+1.59%+2.24%+3.23%+12.68%-50.23%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Biodesix, Inc. stock logo
BDSX
Biodesix
2.50
Moderate Buy$32.50327.63% Upside
DocGo Inc. stock logo
DCGO
DocGo
2.00
Hold$3.24175.77% Upside
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
2.00
Hold$3.1530.98% Upside
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest BDSX, DCGO, SERA, and QIPT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/8/2025
Biodesix, Inc. stock logo
BDSX
Biodesix
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
10/8/2025
DocGo Inc. stock logo
DCGO
DocGo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D)
10/8/2025
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
10/8/2025
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
10/7/2025
DocGo Inc. stock logo
DCGO
DocGo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHoldStrong Sell
9/27/2025
Biodesix, Inc. stock logo
BDSX
Biodesix
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
9/27/2025
DocGo Inc. stock logo
DCGO
DocGo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D)
9/27/2025
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
9/27/2025
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
9/19/2025
Biodesix, Inc. stock logo
BDSX
Biodesix
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price TargetBuy$30.00 ➝ $20.00
8/21/2025
DocGo Inc. stock logo
DCGO
DocGo
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetHold$1.45 ➝ $1.60
(Data available from 10/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Biodesix, Inc. stock logo
BDSX
Biodesix
$71.32M0.78N/AN/A$2.87 per share2.65
DocGo Inc. stock logo
DCGO
DocGo
$616.55M0.19$0.39 per share2.98$3.09 per share0.38
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
$245.91M0.42$0.95 per share2.52$2.49 per share0.97
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
$80K1,426.75N/AN/A$1.40 per share2.16
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Biodesix, Inc. stock logo
BDSX
Biodesix
-$42.93M-$5.80N/AN/AN/A-53.66%-269.67%-43.94%11/7/2025 (Estimated)
DocGo Inc. stock logo
DCGO
DocGo
$19.99M-$0.19N/A14.68N/A-4.20%-3.26%-2.24%11/6/2025 (Estimated)
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
-$6.76M-$0.24N/AN/AN/A-4.30%-9.78%-4.23%12/15/2025 (Estimated)
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
-$32.90M-$0.85N/AN/AN/A-30,306.48%-45.86%-34.31%11/5/2025 (Estimated)

Latest BDSX, DCGO, SERA, and QIPT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/7/2025Q3 2025
Biodesix, Inc. stock logo
BDSX
Biodesix
-$1.60N/AN/AN/AN/AN/A
11/6/2025Q3 2025
DocGo Inc. stock logo
DCGO
DocGo
-$0.09N/AN/AN/A$69.96 millionN/A
11/5/2025Q3 2025
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
-$0.19N/AN/AN/A$0.10 millionN/A
8/11/2025Q3 2025
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
$0.03-$0.07-$0.10-$0.07$80.37 million$58.30 million
8/7/2025Q2 2025
Biodesix, Inc. stock logo
BDSX
Biodesix
-$1.40-$1.60-$0.20-$0.08$18.47 million$20.02 million
8/7/2025Q2 2025
DocGo Inc. stock logo
DCGO
DocGo
-$0.06-$0.11-$0.05-$0.11$77.58 million$80.42 million
8/6/2025Q2 2025
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
-$0.21-$0.16+$0.05-$0.16$0.05 million$0.02 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Biodesix, Inc. stock logo
BDSX
Biodesix
N/AN/AN/AN/AN/A
DocGo Inc. stock logo
DCGO
DocGo
N/AN/AN/AN/AN/A
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
N/AN/AN/AN/AN/A
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Biodesix, Inc. stock logo
BDSX
Biodesix
41.11
2.14
2.14
DocGo Inc. stock logo
DCGO
DocGo
N/A
2.36
2.36
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
0.71
1.15
0.75
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
N/A
1.73
1.73

Institutional Ownership

CompanyInstitutional Ownership
Biodesix, Inc. stock logo
BDSX
Biodesix
20.96%
DocGo Inc. stock logo
DCGO
DocGo
56.44%
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
42.85%
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
54.64%

Insider Ownership

CompanyInsider Ownership
Biodesix, Inc. stock logo
BDSX
Biodesix
30.10%
DocGo Inc. stock logo
DCGO
DocGo
3.80%
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
13.40%
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
13.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Biodesix, Inc. stock logo
BDSX
Biodesix
2207.33 million5.13 millionOptionable
DocGo Inc. stock logo
DCGO
DocGo
4,40797.81 million94.09 millionOptionable
Quipt Home Medical Corp. stock logo
QIPT
Quipt Home Medical
1,20043.44 million37.62 millionOptionable
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
12037.67 million32.59 millionOptionable

Recent News About These Companies

Sera Prognostics: Few Takers For A Great Product Spells Angst
Sera Prognostics (SERA) Q2 Loss Down 4%

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Biodesix stock logo

Biodesix NASDAQ:BDSX

$7.60 -0.23 (-2.94%)
As of 02:13 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR and NGS, and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish the patient's prognosis and help guide treatment decisions. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.

DocGo stock logo

DocGo NASDAQ:DCGO

$1.17 -0.03 (-2.17%)
As of 02:13 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.

Quipt Home Medical stock logo

Quipt Home Medical NASDAQ:QIPT

$2.40 -0.10 (-3.80%)
As of 02:14 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. is headquartered in Wilder, Kentucky.

Sera Prognostics stock logo

Sera Prognostics NASDAQ:SERA

$3.03 -0.17 (-5.31%)
As of 02:10 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preterm birth, preeclampsia, molecular time-to-birth, predictive analytics, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.